MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer (Q34357796)

1 August 2017

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer (English)

1 reference

1 August 2017

1 reference

Michael H Bachmann

7

0 references

Christopher H. Contag

object named as

Christopher H Contag

13

0 references

author name string

Catherine M Shachaf

1

1 reference

1 August 2017

Andrew M Kopelman

2

1 reference

1 August 2017

Constadina Arvanitis

3

1 reference

1 August 2017

Asa Karlsson

4

1 reference

1 August 2017

Shelly Beer

5

1 reference

1 August 2017

Stefanie Mandl

6

1 reference

1 August 2017

Alexander D Borowsky

8

1 reference

1 August 2017

Boris Ruebner

9

1 reference

1 August 2017

Robert D Cardiff

10

1 reference

1 August 2017

Qiwei Yang

11

1 reference

1 August 2017

J Michael Bishop

12

1 reference

1 August 2017

Dean W Felsher

14

1 reference

1 August 2017

language of work or name

English

0 references

publication date

10 October 2004

1 reference

1 August 2017

1 reference

1 August 2017

431

1 reference

1 August 2017

1112-1117

1 reference

1 August 2017

7012

1 reference

https://scigraph.springernature.com/pub.10.1038/nature03043

1 August 2017

0 references

cites work

Systemic therapy for advanced hepatocellular carcinoma: a review.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Molecular themes in oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Cancer revoked: oncogenes as therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Mechanisms of Human Hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Reversible tumorigenesis by MYC in hematopoietic lineages

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Hepatocyte differentiation and liver progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

The role of hepatocytes and oval cells in liver regeneration and repopulation

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Bioluminescence imaging of lymphocyte trafficking in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Tumour dormancy: findings and hypotheses from clinical research on breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Solitary cancer cells as a possible source of tumour dormancy?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Cancer dormancy: opportunities for new therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Wnt proteins are lipid-modified and can act as stem cell growth factors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Therapeutic implications of cancer stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Suppression of intestinal neoplasia by DNA hypomethylation.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Epigenetics wins over genetics: induction of differentiation in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03043

7 January 2021

Identifiers

DOI

10.1038/NATURE03043

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference